NISA INVESTMENT ADVISORS, LLC

Position in PRAX — Praxis Precision Medicines, Inc.

CIK 937615 ST. LOUIS, MO

Position in PRAX

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$2,045,901

+$22,548 QoQ

Shares Held

6,111

-2.7% QoQ

Ownership

0.022%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#146

of 303 holders

Holding Since

Dec 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

NISA INVESTMENT ADVISORS, LLC holds $78,276,385 across 265 Biotechnology names. PRAX ranks #7 (2.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	56,455	$28,042,892
2	REGN	Regeneron Pharmaceuticals, Inc.	19,412	$12,104,158
3	TECH	BIO-TECHNE Corp	68,452	$4,836,133
4	INCY	Incyte Corp	26,479	$3,001,659
5	ALNY	Alnylam Pharmaceuticals, Inc.	9,139	$2,751,113
6	DFTX	Definium Therapeutics, Inc.	48,369	$2,275,277
7	PRAX	Praxis Precision Medicines, Inc. This page	6,111	$2,045,901
8	EXEL	Exelixis, Inc.	36,758	$2,000,002

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,045,901	6,111	-2.7%	Shares	Sole	2026-08-10
2026-03-31	$2,023,353	6,280	-19.2%	Shares	Sole	2026-04-30
2025-12-31	$2,290,129	7,770	+9.0%	Shares	Sole	2026-01-15
2025-09-30	$377,837	7,129	+1033.4%	Shares	Sole	2025-10-23
2025-06-30	$26,449	629	+88.3%	Shares	Sole	2025-07-31
2025-03-31	$12,648	334	+370.4%	Shares	Sole	2025-04-30
2024-12-31	$5,464	71	+22.4%	Shares	Sole	2025-01-17
2024-09-30	$3,337	58	-53.2%	Shares	Sole	2024-10-24
2022-12-31	$295	124	-77.5%	Shares	Sole	2023-02-02
2022-06-30	$1,347	550	-22.5%	Shares	Sole	2022-08-03
2022-03-31	$7,249	710	-81.3%	Shares	Sole	2022-04-29
2021-12-31	$74,860	3,800	—	Shares	Sole	2022-02-03
No filing history on record for this holder in this stock.